Product How it works Pricing Blog FAQ About Contact
Europe

Pharming Group (AMS: PHARM) stock: the official figures

Pharming Group (Pharming Group N.V.) is listed on Euronext Amsterdam under the ticker PHARM and belongs to the health care sector. In fiscal 2025 it reported revenue of $376.1m and a net profit of $2.9m, according to the annual accounts it filed with the regulator.

Identifiers for Pharming Group: ISIN NL0010391025 · LEI 724500DCJ9MPG74JEH91.

Fiscal 2025 figures

Consolidated annual accounts of Pharming Group, in millions of US dollars
Item20252024Change
Revenue$376.1m$297.2m+26.6%
Operating profit$25.8m−$8.6m—
Net profit$2.9m−$11.8m—
Earnings per share$0.004−$0.018—
Operating margin6.9%−2.9%+9.8 pts
Net margin0.8%−4.0%+4.7 pts
Total assets$500.0m$400.0m+25.0%
Equity$277.1m$221.1m+25.4%
Cash$145.3m$54.9m+164.5%
Operating cash flow$54.7m−$1.8m—

Margins are calculated from the filed figures: operating profit and net profit over revenue.

6 fiscal years

Revenue, in millions of US dollars212.22020198.92021205.62022245.32023297.22024376.12025Net profit, in millions of US dollars37.7202016.0202113.72022-10.52023-11.820242.92025
Fiscal yearRevenueOperating profitNet profitEarnings per shareDocument
2025$376.1m$25.8m$2.9m$0.004Annual report
2024$297.2m−$8.6m−$11.8m−$0.018Annual report
2023$245.3m−$5.4m−$10.5m−$0.016Annual report
2022$205.6m$18.2m$13.7m$0.021Annual report
2021$198.9m$13.6m$16.0m$0.025Annual report
2020$212.2m$76.3m$37.7m$0.058—

The full income statement, balance sheet and cash flow statement are in the annual accounts of Pharming Group.

Frequently asked questions about Pharming Group

How much did Pharming Group earn in fiscal 2025?
Pharming Group reported a net profit of $2.9m for fiscal 2025, on revenue of $376.1m. The year before it reported a net loss of $11.8m.
What are the earnings per share of Pharming Group?
They were $0.004 in fiscal 2025, compared with −$0.018 the year before.
Where is Pharming Group listed?
Pharming Group is listed on Euronext Amsterdam under the ticker PHARM and belongs to the health care sector.
What is the ISIN of Pharming Group?
The ISIN of Pharming Group is NL0010391025, the international code that identifies its shares. Its LEI, the legal entity identifier, is 724500DCJ9MPG74JEH91.
Where do the figures for Pharming Group come from?
From the report Pharming Group files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.

Where each figure comes from

The annual accounts come from the report Pharming Group files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year in the table links to its filing. Celsmar reads the tagged figures from the document and does not adjust them: if an item is not in the filing, it is not shown. More detail in data sources and, if you spot an error, in corrections. What Celsmar is and what it costs, in its fact sheet.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.